FDA’s Game-Changing Policy: Accelerating Biosimilar Approvals to Boost Competition and Cut Healthcare Costs
November 1, 2025
In a groundbreaking announcement, the U.S. Food and Drug Administration (FDA) has
- May 23, 2026
Digital therapeutics, apps, and health technology
In a groundbreaking announcement, the U.S. Food and Drug Administration (FDA) has
The recent decision by the Health Resources and Services Administration (HRSA) to
As we transition into November, the biotechnology and pharmaceutical sectors are abuzz
Eli Lilly’s recent decision to halt an experimental pain drug underscores the
In the constantly evolving world of the biopharma industry, staying abreast of
The U.S. Food and Drug Administration (FDA) is taking significant steps to
Eli Lilly, a key player in the biopharmaceutical sector, has made headlines
In the complex landscape of the biopharma industry, drug pricing remains a
CRINETICS REPORT Overview Leadership Mission Products Financials Strengths Challenges News Crinetics Pharmaceuticals,
The landscape of biopharmaceuticals is evolving, paving the way for critical advancements
BioMarin Pharmaceutical has recently announced a significant development regarding its gene therapy,
In the ever-evolving biopharma industry, strategic pivots can significantly influence company direction
In a significant move to enhance the efficiency of drug approval processes,
Alkermes, a prominent name in the biopharmaceutical sector, recently made headlines with
The biotech industry is currently experiencing a significant surge, with companies capitalizing
In a significant leap forward for cancer detection technology, Grail, a pioneering
Galapagos NV shuts down its cell therapy division, cuts 365 jobs, and
In a groundbreaking move for the biopharma sector, Iambic Therapeutics has announced
Antibody-drug conjugates (ADCs) have emerged as a transformative approach in the field
In recent weeks, Alto Neuroscience has witnessed a remarkable surge in its
